A carregar...
Angiotensin II limits NO production by upregulating arginase through a p38 MAPK - ATF-2 pathway
Enhanced vascular arginase activity can impair endothelium-dependent vasorelaxation by decreasing L-arginine availability to endothelial nitric oxide (NO) synthase, thereby reducing NO production and uncoupling NOS function. Elevated angiotensin II (Ang II) is a key component of endothelial dysfunct...
Na minha lista:
| Publicado no: | Eur J Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4412038/ https://ncbi.nlm.nih.gov/pubmed/25446432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2014.10.042 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|